The link between autism spectrum disorder and gut microbiota: A scoping review.
Gut-bug studies in autism are still exploratory, so keep behavior plans behavioral.
01Research in Context
What this study did
Niedfeld et al. (2020) gathered 19 studies that compared gut bacteria in autistic and non-autistic people.
They did not run new experiments. They simply mapped what had been measured and how.
What they found
Most papers saw different bacterial patterns in autism, but the methods were all over the map.
No study linked any microbe change to behavior gains you can target with ABA.
How this fits with other research
Brito et al. (2024) extends this picture. Their large survey of 2,153 autistic people shows GI pain grows with age and that breastfeeding may shield against antibiotic-linked tummy trouble.
Simeon et al. (2025) runs parallel: both reviews flag tiny, mismatched studies. Simeon looked at feeding treatments; Amanda looked at gut bugs. Both shout "thin evidence."
Plate (2025) mirrors the worry. Plate scanned language-sampling papers and likewise found spotty methods and missing kids. The pattern is the same: new area, rushed studies, shaky ground.
Why it matters
You can stop hunting for probiotic protocols in your behavior plans—for now. Track GI pain as a setting event, use Anita’s tip to ask about breastfeeding and antibiotic history, and keep your focus on reinforcement, not bacteria.
Get CEUs on This Topic — Free
The ABA Clubhouse has 60+ on-demand CEUs including ethics, supervision, and clinical topics like this one. Plus a new live CEU every Wednesday.
Add a quick GI discomfort checklist to your session note and treat any pain as a possible setting event.
02At a glance
03Original abstract
Gastrointestinal distress and gut microbial imbalances are commonly found in children with autism spectrum disorder, and therefore may play a key role in the development of the disorder. This scoping review aimed to examine the extent, range and nature of research conducted in the past 6 years that focused on furthering our understanding of autism spectrum disorder and its association with gut microbiota. A literature review was performed with predetermined key words. Studies were screened and selected based on defined inclusion and exclusion criteria. A total of 19 studies were included for final analysis. While there are continuous reports of differences in gut microbiota between autism spectrum disorder and neurotypical individuals, knowledge about the consistency in the presence and abundance of bacterial species, as well as metabolites, remains deficient. Treatments such as special diets, vitamin, prebiotic, probiotic, and microbiota transfer therapy show promising therapeutic potential, yet are in their infancy of investigation. Overall, further research with rigorous methodologies is required to support and strengthen the reliability of existing findings. Future research should aim to increase sample sizes, eliminate biases, and subgroup autism spectrum disorder groups to help accommodate for inter-individual variation. As increasing evidence of a unique autism spectrum disorder microbiome and metabolome is acquired, autism spectrum disorder-specific biomarkers can be identified. These biomarkers have great implications in terms of elucidating the molecular mechanisms of autism spectrum disorder, preventing the onset of autism spectrum disorder, and improving treatments for individuals with autism spectrum disorder.
Autism : the international journal of research and practice, 2020 · doi:10.1177/1362361320913364